Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant CE-marks next-generation Galileo system:

This article was originally published in Clinica

Executive Summary

Guidant has CE-marked for sale in Europe its next-generation Galileo intravascular radiotherapy system. Compared with the firm's original device, the latest Galileo 40/60 automated system can be used to treat longer coronary artery segments with an equivalent source length of up to 60mm and smaller reference lumen diameter arteries as small as 2.4mm. Patients with this type of coronary artery disease are generally prone to higher rates of restenosis, the company says.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072608

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel